Pharmx Technologies Limited · ASX:PHX
Pharmx Technologies — Shareholder Meeting (November 2025)
16 slides from Pharmx Technologies's shareholder meeting presentation, Nov 11, 2025
Slide 1: Chairman's address to shareholders
Annual General Meeting 11 November 2025 Chairman’s address to shareholders 2025 has been a year of strong growth for the Company which was achieved whilst undertaking key strategic investments to support future growth ambitions. Whilst Pharmx enjoys a dominant market position in both Australia and N
Slide 2: Chairman's address (continued)
improvements to help drive the success of the new single platform. This was also the first year the underlying business had a full year of overhead cost allocations, following the finalisation of the sale of the pharmacy software business during the previous financial year. Reported operating cash f
Slide 3: FY26 strategy and About Pharmx
Our FY26 strategy builds on the momentum established in FY25, with a continued focus on delivering ‘more – for – more’ to our partners. We are committed to continuing to enhance our core technology services, ensuring that we maintain the highest and most modern standards of infrastructure, system pe
Slide 4: Pharmx Technologies Limited CEO presentation
For personal use only AGM Presentation PHARMX TECHNOLOGIES LIMITED (ASX:PHX) Tom Culver, CEO November 2025
Slide 5: Leadership team
Leadership team For personal use only Board Chairman Director & COO Director Director Nick England Jon Newbery Jayne Shaw Sandy Mellis Leadership team CEO CFO CTO Head of Marketing GM, Commercial Tom Culver Zoe Hillier Alistair Orchard Gabby Brown Eric Moschietto
Slide 6: Pharmx today
today For personal use only A fully integrated and highly efficient pharmacy technology provider with unrivalled reach, capability and opportunity for revenue growth and scale. ANZ’s most reliable, integrated ordering ANZ's largest pharmacy network offering mission A provider of an increasing range
Slide 7: Our purpose
For personal use only Our purpose To make a difference to healthcare by reimagining how the industry connects.
Slide 8: FY25 highlights
FY25 highlights For personal use only FY25 was a year of transformation and expansions. Demonstrated through the delivery of strong revenue growth supported through a highly efficient, capital light business model and the execution of key strategic milestone that develop long term growth pathways. F
Slide 9: Recent strategic milestones
Recent strategic milestones For personal use only Achieved full pharmacy-side rollout of Pharmx’s single platform - consolidating a complex ecosystem into one powerful, scalable infrastructure designed to transform the customer experience and eliminate key pain points. Supplier Portal Pharmacy Porta
Slide 10: Supplier Portal
For personal use only Supplier Portal SaaS platform - self service onboarding critical for supplier growth, vertical and international market expansion.
Slide 11: Pharmacy Portal
For personal use only Pharmacy Portal A centralised platform giving ready access to order and invoice history, real-time spending insights, and seamless account management.
Slide 12: StockView
For personal use only Pharmacy Portal STOCKVIEW Universal stock availability tool providing the only whole of market consolidated view of stock.
Slide 13: Marketplace
For personal use only Pharmacy Portal MARKETPLACE Marketplace brings together over 40,000 SKUs from hundreds of leading suppliers and manufacturers, including the complete ParagonCare (CH2) range, providing a comprehensive pharmacy procurement platform.
Slide 14: Marketplace opportunity
Marketplace opportunity For personal use only What is Marketplace? What is Marketplace? • Modern, mobile-optimised ordering platform for Australian pharmacies, • A modern, mobile optomised ordering experience for Australian pharmacies, powered by the Pharmx Gateway fully leveraging the Pharmx Gatewa
Slide 15: Strategic Achievements
Strategic Achievements For personal use only Strong year-on-year Clear market leadership; Highly efficient business with Strong growth agenda, performance with continued dominant independent ordering a proven record of disciplined supported by industry tailwinds, uplifts in revenue & activity networ
Slide 16: Thank you
For personal use only Thank you Level 7, 1 Castlereagh Street, Sydney 2000 investor.relations@Pharmx.com.au
Pharmx Technologies — Shareholder Meeting (November 2025) on 6ix